The global CD28 market is growing as CD28-based research gains importance in cancer immunotherapy, autoimmune disease research, and T-cell-based treatments. Advances in monoclonal and bispecific antibodies, immunoassays, flow cytometry, and other research technologies are expanding applications related to CD28. Increasing biopharmaceutical investment and development of novel CD28-targeted...